ロード中...
IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are associated with disease-initiating stem cells that are not eliminated by conventional therapies. Novel therapeutic targets against preleukemic stem cells need to be identified for potentially curative strategies. We conducted paral...
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4432009/ https://ncbi.nlm.nih.gov/pubmed/25810490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-01-621631 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|